Cargando…

Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective

Detalles Bibliográficos
Autores principales:	Lubrano, Ennio, Scriffignano, Silvia, Perrotta, Fabio Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011266/ https://www.ncbi.nlm.nih.gov/pubmed/36495403 http://dx.doi.org/10.1007/s40744-022-00514-0

Ejemplares similares

Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
por: Lubrano, Ennio, et al.
Publicado: (2023)

The “Climb” Towards Minimal Disease Activity in Psoriatic Arthritis
por: Lubrano, Ennio, et al.
Publicado: (2021)

Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study
por: Perrotta, Fabio Massimo, et al.
Publicado: (2023)

Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
por: Perrotta, Fabio Massimo, et al.
Publicado: (2022)

Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
por: Lubrano, Ennio, et al.
Publicado: (2019)

Psoriatic Arthritis in Males and Females: Differences and Similarities
por: Lubrano, Ennio, et al.
Publicado: (2023)

Rheumatology Care in the Face of COVID-19
por: Lubrano, Ennio, et al.
Publicado: (2020)

Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study
por: Scriffignano, Silvia, et al.
Publicado: (2022)

New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review
por: Perrotta, Fabio Massimo, et al.
Publicado: (2021)

Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise – a review
por: Lubrano, Ennio, et al.
Publicado: (2023)

Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis
por: Scriffignano, Silvia, et al.
Publicado: (2023)

Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study
por: Lubrano, Ennio, et al.
Publicado: (2020)

Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices
por: Lubrano, Ennio, et al.
Publicado: (2020)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
por: Lubrano, Ennio, et al.
Publicado: (2016)

MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients
por: Perrotta, Fabio Massimo, et al.
Publicado: (2021)

Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies
por: Lubrano, Ennio, et al.
Publicado: (2014)

Therapeutic Targets for Ankylosing Spondylitis – Recent Insights and Future Prospects
por: Perrotta, Fabio Massimo, et al.
Publicado: (2022)

An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings
por: Perrotta, Fabio Massimo, et al.
Publicado: (2019)

Corticosteroid injection treatment for dactylitis in psoriatic arthritis
por: Carriero, Antonio, et al.
Publicado: (2021)

Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis
por: Montepaone, Monica, et al.
Publicado: (2014)

Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk
por: Novelli, Lucia, et al.
Publicado: (2021)

Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study
por: Perrotta, Fabio Massimo, et al.
Publicado: (2018)

Simple clinical indicators for early psoriatic arthritis detection
por: Caso, Francesco, et al.
Publicado: (2014)

Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
por: Atzeni, Fabiola, et al.
Publicado: (2021)

Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs for Psoriatic Arthritis: Findings and Implications From a Patient Centered Longitudinal Study in Brazil
por: Faria, Ronaldo José, et al.
Publicado: (2022)

Need for redefining needs
por: Asadi-Lari, Mohsen, et al.
Publicado: (2003)

Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
por: Simon, David, et al.
Publicado: (2019)

Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review
por: Kingsley, Gabrielle H, et al.
Publicado: (2015)

Redefining resectability in pancreatic cancer after neoadjuvant therapy: are we any closer?
por: Robertson, Francis P., et al.
Publicado: (2023)

Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
por: Choy, Ernest H
Publicado: (2019)

Genetic counselling for hypertrophic cardiomyopathy: are we ready for it?
por: Vosberg, Hans-Peter
Publicado: (2000)

Vaccination against Lyme disease: Are we ready for it?
por: Kaaijk, Patricia, et al.
Publicado: (2015)

Nuclear Medicine in India: Are We Pandemic Ready?
por: Puranik, Ameya D
Publicado: (2020)

Psoriatic arthritis synovial histopathology: commentary on the article by Kruithof and colleagues
por: FitzGerald, Oliver
Publicado: (2005)

Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype
por: Marchesoni, Antonio
Publicado: (2018)

A new player in psoriatic arthritis: a JAK inhibitor
por: Sakkas, Lazaros I.
Publicado: (2017)

Multiculturalism and interculturalism: redefining nationhood and solidarity
por: Kastoryano, Riva
Publicado: (2018)

Are we ready for the new fatal Coronavirus: scenario of Pakistan?
por: Ahmad, Tauseef, et al.
Publicado: (2020)

Commentary: Are we always ready for a challenging surprise?
por: Rackauskas, Mindaugas, et al.
Publicado: (2021)

Advances in understanding gray matter pathology in multiple sclerosis: Are we ready to redefine disease pathogenesis?
por: Zivadinov, Robert, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_usbn912j6otv7k94h1sjsqult2